These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10910951)

  • 1. Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells.
    Wang MH; Kurtz AL; Chen Y
    Carcinogenesis; 2000 Aug; 21(8):1507-12. PubMed ID: 10910951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines.
    Chen YQ; Zhou YQ; Angeloni D; Kurtz AL; Qiang XZ; Wang MH
    Exp Cell Res; 2000 Nov; 261(1):229-38. PubMed ID: 11082293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel variant of the RON receptor tyrosine kinase derived from colorectal carcinoma cells which lacks tyrosine phosphorylation but induces cell migration.
    Wang D; Lao WF; Kuang YY; Geng SM; Mo LJ; He C
    Exp Cell Res; 2012 Dec; 318(20):2548-58. PubMed ID: 22975341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype.
    Collesi C; Santoro MM; Gaudino G; Comoglio PM
    Mol Cell Biol; 1996 Oct; 16(10):5518-26. PubMed ID: 8816464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in a defined extracellular region of the RON receptor tyrosine kinase promote RON-mediated motile and invasive phenotypes in epithelial cells.
    Zhang K; Zhou YQ; Yao HP; Wang MH
    Int J Oncol; 2010 Jan; 36(1):255-64. PubMed ID: 19956854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential.
    Zhou YQ; He C; Chen YQ; Wang D; Wang MH
    Oncogene; 2003 Jan; 22(2):186-97. PubMed ID: 12527888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel RON splice variant lacking exon 2 activates the PI3K/AKT pathway via PTEN phosphorylation in colorectal carcinoma cells.
    Ling Y; Kuang Y; Chen LL; Lao WF; Zhu YR; Wang LQ; Wang D
    Oncotarget; 2017 Jun; 8(24):39101-39116. PubMed ID: 28388571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.
    Peace BE; Hughes MJ; Degen SJ; Waltz SE
    Oncogene; 2001 Sep; 20(43):6142-51. PubMed ID: 11593422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking tumorigenic activities of colorectal cancer cells by a splicing RON receptor variant defective in the tyrosine kinase domain.
    Wang MH; Lao WF; Wang D; Luo YL; Yao HP
    Cancer Biol Ther; 2007 Jul; 6(7):1121-9. PubMed ID: 17611409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
    Iwama A; Yamaguchi N; Suda T
    EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered exon usage in the juxtamembrane domain of mouse and human RON regulates receptor activity and signaling specificity.
    Wei X; Hao L; Ni S; Liu Q; Xu J; Correll PH
    J Biol Chem; 2005 Dec; 280(48):40241-51. PubMed ID: 16166096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of both tyrosine residues 1330 and 1337 in the C-terminal tail of the RON receptor tyrosine kinase for epithelial cell scattering and migration.
    Xiao ZQ; Chen YQ; Wang MH
    Biochem Biophys Res Commun; 2000 Jan; 267(2):669-75. PubMed ID: 10631120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of RON receptor tyrosine kinase and its splicing variant in malignant and non-malignant human colonic mucosa.
    Okino T; Egami H; Ohmachi H; Takai E; Tamori Y; Nakagawa K; Nakano S; Akagi J; Sakamoto O; Suda T; Ogawa M
    Int J Oncol; 1999 Oct; 15(4):709-14. PubMed ID: 10493952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.
    Ma Q; Zhang K; Yao HP; Zhou YQ; Padhye S; Wang MH
    Int J Oncol; 2010 Jun; 36(6):1551-61. PubMed ID: 20428780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells.
    Xu XM; Wang D; Shen Q; Chen YQ; Wang MH
    Oncogene; 2004 Nov; 23(52):8464-74. PubMed ID: 15378025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.
    Chakedis J; French R; Babicky M; Jaquish D; Howard H; Mose E; Lam R; Holman P; Miyamoto J; Walterscheid Z; Lowy AM
    Oncogene; 2016 Jun; 35(25):3249-59. PubMed ID: 26477314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro.
    Medico E; Mongiovi AM; Huff J; Jelinek MA; Follenzi A; Gaudino G; Parsons JT; Comoglio PM
    Mol Biol Cell; 1996 Apr; 7(4):495-504. PubMed ID: 8730094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression.
    Bardella C; Costa B; Maggiora P; Patane' S; Olivero M; Ranzani GN; De Bortoli M; Comoglio PM; Di Renzo MF
    Cancer Res; 2004 Aug; 64(15):5154-61. PubMed ID: 15289319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
    Wang MH; Wang D; Chen YQ
    Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin-mediated RON growth factor receptor phosphorylation requires tyrosine kinase activity of both the receptor and c-Src.
    Danilkovitch-Miagkova A; Angeloni D; Skeel A; Donley S; Lerman M; Leonard EJ
    J Biol Chem; 2000 May; 275(20):14783-6. PubMed ID: 10747844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.